Decreased classical monocytes and CD163 expression in TB patients: an indicator of drug resistance
- 13 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Brazilian Journal of Microbiology
- Vol. 52 (2), 607-617
- https://doi.org/10.1007/s42770-021-00454-x
Abstract
Tuberculosis (TB) is a disease instigated by Mycobacterium tuberculosis. Peripheral blood monocytes represent highly efficient effector cells of innate immunity against TB. Little is known about monocyte subsets and their potential involvement in the development of M. tuberculosis drug resistance in patients with TB. This study was conducted to investigate alterations in monocyte subsets, CD163 expression on monocytes, and its serum level in patients without and with rifampicin resistance TB (RR-TB) and healthy controls. A total of 164 patients with TB (84 without RR-TB and 80 patients with RR-TB) and 85 healthy controls were enrolled in this study. The percentages of various monocyte subsets and surface expression of CD163 on monocytes were quantitatively determined using flow cytometry. The serum level of CD163 was determined by commercially available ELISA kits. Decreased frequency of classical monocytes was detected in patients with RR-TB. Non-classical monocytes were decreased in patients without RR-TB; however, intermediate monocytes were raised in patients with RR-TB. The serum level of CD163 was decreased in patients of RR-TB that showsed a positive correlation with the frequency of CD14++CD16–CD163+ and CD14++CD16+CD163+ monocytes. It is concluded that decreased classical monocytes and sCD163 in patients with RR-TB could be an indicator of drug resistance.Keywords
This publication has 29 references indexed in Scilit:
- Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective StudyPLOS ONE, 2012
- Increased frequency and cell death of CD16+ monocytes with Mycobacterium tuberculosis infectionTuberculosis, 2011
- Differential Expression of CD163 on Monocyte Subsets in Healthy and HIV-1 Infected IndividualsPLOS ONE, 2011
- Paradoxical role of CD16+CCR2+CCR5+ monocytes in tuberculosis: efficient APC in pleural effusion but also mark disease severity in bloodJournal of Leukocyte Biology, 2011
- Nomenclature of monocytes and dendritic cells in bloodBlood, 2010
- Tuberculosis drug development: Progress, challenges, and the road aheadTuberculosis, 2010
- Peripheral Blood CD14high CD16+ Monocytes are Main Producers of IL‐10Scandinavian Journal of Immunology, 2008
- Functional and phenotypic changes in monocytes from patients with tuberculosis are reversed with treatmentMicrobes and Infection, 2006
- Predictive value of soluble haemoglobin scavenger receptor CD163 serum levels for survival in verified tuberculosis patientsClinical Microbiology & Infection, 2005
- The production of tumour necrosis factor-alpha is decreased in peripheral blood mononuclear cells from multidrug-resistant tuberculosis patients following stimulation with the 30-kDa antigen of Mycobacterium tuberculosisClinical and Experimental Immunology, 2003